GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Flowr Corp (TSXV:FLWR.H) » Definitions » 5-Year EBITDA Growth Rate

The Flowr (TSXV:FLWR.H) 5-Year EBITDA Growth Rate : 0.00% (As of Sep. 2022)


View and export this data going back to 2017. Start your Free Trial

What is The Flowr 5-Year EBITDA Growth Rate?

The Flowr's EBITDA per Share for the three months ended in Sep. 2022 was C$-0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of The Flowr's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, The Flowr's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Flowr's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Flowr's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where The Flowr's 5-Year EBITDA Growth Rate falls into.



The Flowr 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


The Flowr  (TSXV:FLWR.H) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


The Flowr 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of The Flowr's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


The Flowr (TSXV:FLWR.H) Business Description

Traded in Other Exchanges
N/A
Address
9590 McCarthy Road, Kelowna, BC, CAN, V4V 1R2
The Flowr Corp is a Toronto-headquartered cannabis company with operations in Canada and Europe. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a R&D facility that is awaiting licensing from Health Canada. From this campus, Flowr produces recreational and medicinal products. Internationally, it intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in Portugal.

The Flowr (TSXV:FLWR.H) Headlines

No Headlines